Literature DB >> 8214113

Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure.

R P Shannon1, K Komamura, Y T Shen, S P Bishop, S F Vatner.   

Abstract

The purpose of the present investigation was to examine coronary flow and vasodilator reserve in conscious, chronically instrumented dogs with pacing-induced heart failure, a model of severe biventricular cardiomyopathy devoid of significant hypertrophy. Twelve dogs were studied after 28 days of rapid right ventricular pacing and were compared with six sham-operated controls. Left ventricular (LV) average transmural flow was significantly less in conscious dogs with pacing-induced heart failure, whereas the endocardial-to-epicardial flow ratio was not significantly different. In response to near maximal coronary vasodilation with adenosine, subepicardial coronary flow and vasodilator reserve were preserved in congestive heart failure (CHF), yet there was evidence of impaired subendocardial flow and vasodilator reserve, and the endocardial-to-epicardial ratio was significantly less. When the markedly elevated LV end-diastolic pressure was normalized in heart failure, there was restoration of subendocardial coronary flow reserve and a normalization of the endocardial-to-epicardial ratio. Thus, in CHF, there is impaired coronary flow and vasodilator reserve that is selective to the subendocardium of the LV. At this point in the heart failure process, this impairment is not associated with structural changes but is a consequence of the marked elevation in LV end-diastolic pressure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214113     DOI: 10.1152/ajpheart.1993.265.3.H801

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Regulating myocardial blood flow in health and disease.

Authors:  Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 2.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 3.  Left ventricular size and shape: determinants of mechanical signal transduction pathways.

Authors:  Douglas L Mann
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

Review 4.  Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling.

Authors:  Alfred W H Stanley; Constantine L Athanasuleas; Gerald D Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

Review 5.  Cardiac sympathetic afferent reflexes in heart failure.

Authors:  W Wang; R Ma
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

6.  Remodeling of left circumflex coronary arterial tree in pacing-induced heart failure.

Authors:  Yunlong Huo; Ghassan S Kassab
Journal:  J Appl Physiol (1985)       Date:  2015-07-09

Review 7.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 8.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  What About Tachycardia-induced Cardiomyopathy?

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11

10.  Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells.

Authors:  Georgina M Ellison; Daniele Torella; Ioannis Karakikes; Saranya Purushothaman; Antonio Curcio; Cosimo Gasparri; Ciro Indolfi; N Tim Cable; David F Goldspink; Bernardo Nadal-Ginard
Journal:  J Biol Chem       Date:  2007-01-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.